What Celldex Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 2 |
| Total trades | 0 | 8 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 73,448 |
| Disposed | 0 | 53,464 |
| Net activity | +0 | +19,984 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Martin Samuel Bates | SVP AND CFO | Jan 02 | Exercise / conversion · M | +4,817 | $10.38 | +$50K | 32,942 |
| Pepin Ronald | SR. VP & CBO | Dec 15 | Exercise / conversion · M | +11,000 | $2.78 | +$30.6K | 20,097 |
| Pepin Ronald | SR. VP & CBO | Dec 15 | Exercise / conversion · M | +8,333 | $9.02 | +$75.1K | 9,097 |
| Jimenez Freddy A. | SVP & GENERAL COUNSEL | Dec 04 | Open-market sale · S | −4,166 | $29.10 | −$121K | 30,796 |
| Wright Richard M. | Insider | Nov 13 | Open-market sale · S | −49,298 | $24.00 | −$1.18M | 20,833 |
| Wright Richard M. | Insider | Nov 13 | Exercise / conversion · M | +15,750 | $22.48 | +$354K | 70,131 |
| Wright Richard M. | Insider | Nov 13 | Exercise / conversion · M | +26,672 | $10.38 | +$277K | 54,381 |
| Wright Richard M. | Insider | Nov 13 | Exercise / conversion · M | +6,876 | $9.02 | +$62K | 27,709 |
| Jimenez Freddy A. | SVP & GENERAL COUNSEL | Aug 13 | Open-market sale · S | −430 | $25.42 | −$10.9K | 34,962 |
| Jimenez Freddy A. | SVP & GENERAL COUNSEL | Aug 13 | Open-market sale · S | −341 | $23.95 | −$8.17K | 35,392 |
| Marino James J | Director | Nov 18 | Gift · G | −10,500 | — | — | 2,204 |
| Marucci Anthony S | PRESIDENT & CEO | Nov 11 | Open-market buy · P | +11,500 | $26.82 | +$308K | 40,284 |
| Martin Samuel Bates | SVP AND CFO | Jun 14 | Open-market sale · S | −17,172 | $35.42 | −$608K | 28,125 |
| Martin Samuel Bates | SVP AND CFO | Jun 14 | Exercise / conversion · M | +16,968 | $10.38 | +$176K | 45,297 |
| Martin Samuel Bates | SVP AND CFO | Jun 14 | Exercise / conversion · M | +3,201 | $9.02 | +$28.9K | 28,329 |
| Crowley Elizabeth | SR. VP & CPDO | Jun 14 | Open-market sale · S | −30,000 | $34.87 | −$1.05M | 9,074 |
| Crowley Elizabeth | SR. VP & CPDO | Jun 14 | Exercise / conversion · M | +30,000 | $10.38 | +$311K | 39,074 |
| Young Diane C. | SVP, CHIEF MEDICAL OFFICER | Jun 11 | Exercise / conversion · M | +15,000 | $2.71 | +$40.7K | 17,115 |
| Crowley Elizabeth | SR. VP & CPDO | Jun 07 | Open-market sale · S | −15,000 | $35.06 | −$526K | 9,074 |
| Crowley Elizabeth | SR. VP & CPDO | Jun 07 | Exercise / conversion · M | +7,500 | $9.02 | +$67.6K | 24,074 |
Loading...
